1
  • Category
  • Region
U.S. (TOLL FREE)
+1 (315) 215-3225
1
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Safety Pharmacology Market Research Report 2025
Published Date: January 2025
|
Report Code: QYRE-Auto-16F11941
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Safety Pharmacology Market Research Report 2022
BUY CHAPTERS

Global Safety Pharmacology Market Research Report 2025

Code: QYRE-Auto-16F11941
Report
January 2025
Pages:86
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Safety Pharmacology Market Size

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years.

Safety Pharmacology Market

Safety Pharmacology Market

The global market for Safety Pharmacology was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Safety Pharmacology, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Safety Pharmacology.
The Safety Pharmacology market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Safety Pharmacology market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Safety Pharmacology companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Safety Pharmacology Market Report

Report Metric Details
Report Name Safety Pharmacology Market
CAGR 5%
Segment by Type
  • Respiratory System
  • Central Nervous System
  • Cardiovascular System
  • Medical Device Safety Evaluation
  • Natural Product Safety Evaluation
  • Others
Segment by Application
  • Large Animal Species
  • Small Animal Species
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Thermo Fisher Scientific, PerkinElmer, Merck, Charles River, TKTsweden, Pharmaron, Reaction Biology, Eurofins Discovery, Frontage Laboratories, Tergus Pharma, QIMA Life Sciences
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Safety Pharmacology company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Safety Pharmacology Market report?

Ans: The main players in the Safety Pharmacology Market are Thermo Fisher Scientific, PerkinElmer, Merck, Charles River, TKTsweden, Pharmaron, Reaction Biology, Eurofins Discovery, Frontage Laboratories, Tergus Pharma, QIMA Life Sciences

What are the Application segmentation covered in the Safety Pharmacology Market report?

Ans: The Applications covered in the Safety Pharmacology Market report are Large Animal Species, Small Animal Species

What are the Type segmentation covered in the Safety Pharmacology Market report?

Ans: The Types covered in the Safety Pharmacology Market report are Respiratory System, Central Nervous System, Cardiovascular System, Medical Device Safety Evaluation, Natural Product Safety Evaluation, Others

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Safety Pharmacology Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Respiratory System
1.2.3 Central Nervous System
1.2.4 Cardiovascular System
1.2.5 Medical Device Safety Evaluation
1.2.6 Natural Product Safety Evaluation
1.2.7 Others
1.3 Market by Application
1.3.1 Global Safety Pharmacology Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Large Animal Species
1.3.3 Small Animal Species
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Safety Pharmacology Market Perspective (2020-2031)
2.2 Global Safety Pharmacology Growth Trends by Region
2.2.1 Global Safety Pharmacology Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Safety Pharmacology Historic Market Size by Region (2020-2025)
2.2.3 Safety Pharmacology Forecasted Market Size by Region (2026-2031)
2.3 Safety Pharmacology Market Dynamics
2.3.1 Safety Pharmacology Industry Trends
2.3.2 Safety Pharmacology Market Drivers
2.3.3 Safety Pharmacology Market Challenges
2.3.4 Safety Pharmacology Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Safety Pharmacology Players by Revenue
3.1.1 Global Top Safety Pharmacology Players by Revenue (2020-2025)
3.1.2 Global Safety Pharmacology Revenue Market Share by Players (2020-2025)
3.2 Global Safety Pharmacology Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Safety Pharmacology Revenue
3.4 Global Safety Pharmacology Market Concentration Ratio
3.4.1 Global Safety Pharmacology Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Safety Pharmacology Revenue in 2024
3.5 Global Key Players of Safety Pharmacology Head office and Area Served
3.6 Global Key Players of Safety Pharmacology, Product and Application
3.7 Global Key Players of Safety Pharmacology, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Safety Pharmacology Breakdown Data by Type
4.1 Global Safety Pharmacology Historic Market Size by Type (2020-2025)
4.2 Global Safety Pharmacology Forecasted Market Size by Type (2026-2031)
5 Safety Pharmacology Breakdown Data by Application
5.1 Global Safety Pharmacology Historic Market Size by Application (2020-2025)
5.2 Global Safety Pharmacology Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Safety Pharmacology Market Size (2020-2031)
6.2 North America Safety Pharmacology Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Safety Pharmacology Market Size by Country (2020-2025)
6.4 North America Safety Pharmacology Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Safety Pharmacology Market Size (2020-2031)
7.2 Europe Safety Pharmacology Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Safety Pharmacology Market Size by Country (2020-2025)
7.4 Europe Safety Pharmacology Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Safety Pharmacology Market Size (2020-2031)
8.2 Asia-Pacific Safety Pharmacology Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Safety Pharmacology Market Size by Region (2020-2025)
8.4 Asia-Pacific Safety Pharmacology Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Safety Pharmacology Market Size (2020-2031)
9.2 Latin America Safety Pharmacology Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Safety Pharmacology Market Size by Country (2020-2025)
9.4 Latin America Safety Pharmacology Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Safety Pharmacology Market Size (2020-2031)
10.2 Middle East & Africa Safety Pharmacology Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Safety Pharmacology Market Size by Country (2020-2025)
10.4 Middle East & Africa Safety Pharmacology Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Thermo Fisher Scientific
11.1.1 Thermo Fisher Scientific Company Details
11.1.2 Thermo Fisher Scientific Business Overview
11.1.3 Thermo Fisher Scientific Safety Pharmacology Introduction
11.1.4 Thermo Fisher Scientific Revenue in Safety Pharmacology Business (2020-2025)
11.1.5 Thermo Fisher Scientific Recent Development
11.2 PerkinElmer
11.2.1 PerkinElmer Company Details
11.2.2 PerkinElmer Business Overview
11.2.3 PerkinElmer Safety Pharmacology Introduction
11.2.4 PerkinElmer Revenue in Safety Pharmacology Business (2020-2025)
11.2.5 PerkinElmer Recent Development
11.3 Merck
11.3.1 Merck Company Details
11.3.2 Merck Business Overview
11.3.3 Merck Safety Pharmacology Introduction
11.3.4 Merck Revenue in Safety Pharmacology Business (2020-2025)
11.3.5 Merck Recent Development
11.4 Charles River
11.4.1 Charles River Company Details
11.4.2 Charles River Business Overview
11.4.3 Charles River Safety Pharmacology Introduction
11.4.4 Charles River Revenue in Safety Pharmacology Business (2020-2025)
11.4.5 Charles River Recent Development
11.5 TKTsweden
11.5.1 TKTsweden Company Details
11.5.2 TKTsweden Business Overview
11.5.3 TKTsweden Safety Pharmacology Introduction
11.5.4 TKTsweden Revenue in Safety Pharmacology Business (2020-2025)
11.5.5 TKTsweden Recent Development
11.6 Pharmaron
11.6.1 Pharmaron Company Details
11.6.2 Pharmaron Business Overview
11.6.3 Pharmaron Safety Pharmacology Introduction
11.6.4 Pharmaron Revenue in Safety Pharmacology Business (2020-2025)
11.6.5 Pharmaron Recent Development
11.7 Reaction Biology
11.7.1 Reaction Biology Company Details
11.7.2 Reaction Biology Business Overview
11.7.3 Reaction Biology Safety Pharmacology Introduction
11.7.4 Reaction Biology Revenue in Safety Pharmacology Business (2020-2025)
11.7.5 Reaction Biology Recent Development
11.8 Eurofins Discovery
11.8.1 Eurofins Discovery Company Details
11.8.2 Eurofins Discovery Business Overview
11.8.3 Eurofins Discovery Safety Pharmacology Introduction
11.8.4 Eurofins Discovery Revenue in Safety Pharmacology Business (2020-2025)
11.8.5 Eurofins Discovery Recent Development
11.9 Frontage Laboratories
11.9.1 Frontage Laboratories Company Details
11.9.2 Frontage Laboratories Business Overview
11.9.3 Frontage Laboratories Safety Pharmacology Introduction
11.9.4 Frontage Laboratories Revenue in Safety Pharmacology Business (2020-2025)
11.9.5 Frontage Laboratories Recent Development
11.10 Tergus Pharma
11.10.1 Tergus Pharma Company Details
11.10.2 Tergus Pharma Business Overview
11.10.3 Tergus Pharma Safety Pharmacology Introduction
11.10.4 Tergus Pharma Revenue in Safety Pharmacology Business (2020-2025)
11.10.5 Tergus Pharma Recent Development
11.11 QIMA Life Sciences
11.11.1 QIMA Life Sciences Company Details
11.11.2 QIMA Life Sciences Business Overview
11.11.3 QIMA Life Sciences Safety Pharmacology Introduction
11.11.4 QIMA Life Sciences Revenue in Safety Pharmacology Business (2020-2025)
11.11.5 QIMA Life Sciences Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
 Table 1. Global Safety Pharmacology Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
 Table 2. Key Players of Respiratory System
 Table 3. Key Players of Central Nervous System
 Table 4. Key Players of Cardiovascular System
 Table 5. Key Players of Medical Device Safety Evaluation
 Table 6. Key Players of Natural Product Safety Evaluation
 Table 7. Key Players of Others
 Table 8. Global Safety Pharmacology Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
 Table 9. Global Safety Pharmacology Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 10. Global Safety Pharmacology Market Size by Region (2020-2025) & (US$ Million)
 Table 11. Global Safety Pharmacology Market Share by Region (2020-2025)
 Table 12. Global Safety Pharmacology Forecasted Market Size by Region (2026-2031) & (US$ Million)
 Table 13. Global Safety Pharmacology Market Share by Region (2026-2031)
 Table 14. Safety Pharmacology Market Trends
 Table 15. Safety Pharmacology Market Drivers
 Table 16. Safety Pharmacology Market Challenges
 Table 17. Safety Pharmacology Market Restraints
 Table 18. Global Safety Pharmacology Revenue by Players (2020-2025) & (US$ Million)
 Table 19. Global Safety Pharmacology Market Share by Players (2020-2025)
 Table 20. Global Top Safety Pharmacology Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Safety Pharmacology as of 2024)
 Table 21. Ranking of Global Top Safety Pharmacology Companies by Revenue (US$ Million) in 2024
 Table 22. Global 5 Largest Players Market Share by Safety Pharmacology Revenue (CR5 and HHI) & (2020-2025)
 Table 23. Global Key Players of Safety Pharmacology, Headquarters and Area Served
 Table 24. Global Key Players of Safety Pharmacology, Product and Application
 Table 25. Global Key Players of Safety Pharmacology, Date of Enter into This Industry
 Table 26. Mergers & Acquisitions, Expansion Plans
 Table 27. Global Safety Pharmacology Market Size by Type (2020-2025) & (US$ Million)
 Table 28. Global Safety Pharmacology Revenue Market Share by Type (2020-2025)
 Table 29. Global Safety Pharmacology Forecasted Market Size by Type (2026-2031) & (US$ Million)
 Table 30. Global Safety Pharmacology Revenue Market Share by Type (2026-2031)
 Table 31. Global Safety Pharmacology Market Size by Application (2020-2025) & (US$ Million)
 Table 32. Global Safety Pharmacology Revenue Market Share by Application (2020-2025)
 Table 33. Global Safety Pharmacology Forecasted Market Size by Application (2026-2031) & (US$ Million)
 Table 34. Global Safety Pharmacology Revenue Market Share by Application (2026-2031)
 Table 35. North America Safety Pharmacology Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 36. North America Safety Pharmacology Market Size by Country (2020-2025) & (US$ Million)
 Table 37. North America Safety Pharmacology Market Size by Country (2026-2031) & (US$ Million)
 Table 38. Europe Safety Pharmacology Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 39. Europe Safety Pharmacology Market Size by Country (2020-2025) & (US$ Million)
 Table 40. Europe Safety Pharmacology Market Size by Country (2026-2031) & (US$ Million)
 Table 41. Asia-Pacific Safety Pharmacology Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 42. Asia-Pacific Safety Pharmacology Market Size by Region (2020-2025) & (US$ Million)
 Table 43. Asia-Pacific Safety Pharmacology Market Size by Region (2026-2031) & (US$ Million)
 Table 44. Latin America Safety Pharmacology Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 45. Latin America Safety Pharmacology Market Size by Country (2020-2025) & (US$ Million)
 Table 46. Latin America Safety Pharmacology Market Size by Country (2026-2031) & (US$ Million)
 Table 47. Middle East & Africa Safety Pharmacology Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 48. Middle East & Africa Safety Pharmacology Market Size by Country (2020-2025) & (US$ Million)
 Table 49. Middle East & Africa Safety Pharmacology Market Size by Country (2026-2031) & (US$ Million)
 Table 50. Thermo Fisher Scientific Company Details
 Table 51. Thermo Fisher Scientific Business Overview
 Table 52. Thermo Fisher Scientific Safety Pharmacology Product
 Table 53. Thermo Fisher Scientific Revenue in Safety Pharmacology Business (2020-2025) & (US$ Million)
 Table 54. Thermo Fisher Scientific Recent Development
 Table 55. PerkinElmer Company Details
 Table 56. PerkinElmer Business Overview
 Table 57. PerkinElmer Safety Pharmacology Product
 Table 58. PerkinElmer Revenue in Safety Pharmacology Business (2020-2025) & (US$ Million)
 Table 59. PerkinElmer Recent Development
 Table 60. Merck Company Details
 Table 61. Merck Business Overview
 Table 62. Merck Safety Pharmacology Product
 Table 63. Merck Revenue in Safety Pharmacology Business (2020-2025) & (US$ Million)
 Table 64. Merck Recent Development
 Table 65. Charles River Company Details
 Table 66. Charles River Business Overview
 Table 67. Charles River Safety Pharmacology Product
 Table 68. Charles River Revenue in Safety Pharmacology Business (2020-2025) & (US$ Million)
 Table 69. Charles River Recent Development
 Table 70. TKTsweden Company Details
 Table 71. TKTsweden Business Overview
 Table 72. TKTsweden Safety Pharmacology Product
 Table 73. TKTsweden Revenue in Safety Pharmacology Business (2020-2025) & (US$ Million)
 Table 74. TKTsweden Recent Development
 Table 75. Pharmaron Company Details
 Table 76. Pharmaron Business Overview
 Table 77. Pharmaron Safety Pharmacology Product
 Table 78. Pharmaron Revenue in Safety Pharmacology Business (2020-2025) & (US$ Million)
 Table 79. Pharmaron Recent Development
 Table 80. Reaction Biology Company Details
 Table 81. Reaction Biology Business Overview
 Table 82. Reaction Biology Safety Pharmacology Product
 Table 83. Reaction Biology Revenue in Safety Pharmacology Business (2020-2025) & (US$ Million)
 Table 84. Reaction Biology Recent Development
 Table 85. Eurofins Discovery Company Details
 Table 86. Eurofins Discovery Business Overview
 Table 87. Eurofins Discovery Safety Pharmacology Product
 Table 88. Eurofins Discovery Revenue in Safety Pharmacology Business (2020-2025) & (US$ Million)
 Table 89. Eurofins Discovery Recent Development
 Table 90. Frontage Laboratories Company Details
 Table 91. Frontage Laboratories Business Overview
 Table 92. Frontage Laboratories Safety Pharmacology Product
 Table 93. Frontage Laboratories Revenue in Safety Pharmacology Business (2020-2025) & (US$ Million)
 Table 94. Frontage Laboratories Recent Development
 Table 95. Tergus Pharma Company Details
 Table 96. Tergus Pharma Business Overview
 Table 97. Tergus Pharma Safety Pharmacology Product
 Table 98. Tergus Pharma Revenue in Safety Pharmacology Business (2020-2025) & (US$ Million)
 Table 99. Tergus Pharma Recent Development
 Table 100. QIMA Life Sciences Company Details
 Table 101. QIMA Life Sciences Business Overview
 Table 102. QIMA Life Sciences Safety Pharmacology Product
 Table 103. QIMA Life Sciences Revenue in Safety Pharmacology Business (2020-2025) & (US$ Million)
 Table 104. QIMA Life Sciences Recent Development
 Table 105. Research Programs/Design for This Report
 Table 106. Key Data Information from Secondary Sources
 Table 107. Key Data Information from Primary Sources
 Table 108. Authors List of This Report


List of Figures
 Figure 1. Safety Pharmacology Picture
 Figure 2. Global Safety Pharmacology Market Size Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Safety Pharmacology Market Share by Type: 2024 VS 2031
 Figure 4. Respiratory System Features
 Figure 5. Central Nervous System Features
 Figure 6. Cardiovascular System Features
 Figure 7. Medical Device Safety Evaluation Features
 Figure 8. Natural Product Safety Evaluation Features
 Figure 9. Others Features
 Figure 10. Global Safety Pharmacology Market Size by Application (2020-2031) & (US$ Million)
 Figure 11. Global Safety Pharmacology Market Share by Application: 2024 VS 2031
 Figure 12. Large Animal Species Case Studies
 Figure 13. Small Animal Species Case Studies
 Figure 14. Safety Pharmacology Report Years Considered
 Figure 15. Global Safety Pharmacology Market Size (US$ Million), Year-over-Year: 2020-2031
 Figure 16. Global Safety Pharmacology Market Size, (US$ Million), 2020 VS 2024 VS 2031
 Figure 17. Global Safety Pharmacology Market Share by Region: 2024 VS 2031
 Figure 18. Global Safety Pharmacology Market Share by Players in 2024
 Figure 19. Global Top Safety Pharmacology Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Safety Pharmacology as of 2024)
 Figure 20. The Top 10 and 5 Players Market Share by Safety Pharmacology Revenue in 2024
 Figure 21. North America Safety Pharmacology Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 22. North America Safety Pharmacology Market Share by Country (2020-2031)
 Figure 23. United States Safety Pharmacology Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 24. Canada Safety Pharmacology Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 25. Europe Safety Pharmacology Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 26. Europe Safety Pharmacology Market Share by Country (2020-2031)
 Figure 27. Germany Safety Pharmacology Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 28. France Safety Pharmacology Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 29. U.K. Safety Pharmacology Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 30. Italy Safety Pharmacology Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 31. Russia Safety Pharmacology Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 32. Nordic Countries Safety Pharmacology Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 33. Asia-Pacific Safety Pharmacology Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 34. Asia-Pacific Safety Pharmacology Market Share by Region (2020-2031)
 Figure 35. China Safety Pharmacology Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 36. Japan Safety Pharmacology Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 37. South Korea Safety Pharmacology Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 38. Southeast Asia Safety Pharmacology Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 39. India Safety Pharmacology Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 40. Australia Safety Pharmacology Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 41. Latin America Safety Pharmacology Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 42. Latin America Safety Pharmacology Market Share by Country (2020-2031)
 Figure 43. Mexico Safety Pharmacology Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 44. Brazil Safety Pharmacology Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 45. Middle East & Africa Safety Pharmacology Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 46. Middle East & Africa Safety Pharmacology Market Share by Country (2020-2031)
 Figure 47. Turkey Safety Pharmacology Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 48. Saudi Arabia Safety Pharmacology Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 49. UAE Safety Pharmacology Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 50. Thermo Fisher Scientific Revenue Growth Rate in Safety Pharmacology Business (2020-2025)
 Figure 51. PerkinElmer Revenue Growth Rate in Safety Pharmacology Business (2020-2025)
 Figure 52. Merck Revenue Growth Rate in Safety Pharmacology Business (2020-2025)
 Figure 53. Charles River Revenue Growth Rate in Safety Pharmacology Business (2020-2025)
 Figure 54. TKTsweden Revenue Growth Rate in Safety Pharmacology Business (2020-2025)
 Figure 55. Pharmaron Revenue Growth Rate in Safety Pharmacology Business (2020-2025)
 Figure 56. Reaction Biology Revenue Growth Rate in Safety Pharmacology Business (2020-2025)
 Figure 57. Eurofins Discovery Revenue Growth Rate in Safety Pharmacology Business (2020-2025)
 Figure 58. Frontage Laboratories Revenue Growth Rate in Safety Pharmacology Business (2020-2025)
 Figure 59. Tergus Pharma Revenue Growth Rate in Safety Pharmacology Business (2020-2025)
 Figure 60. QIMA Life Sciences Revenue Growth Rate in Safety Pharmacology Business (2020-2025)
 Figure 61. Bottom-up and Top-down Approaches for This Report
 Figure 62. Data Triangulation
 Figure 63. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Nano Dimension

SIMILAR REPORTS

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

RELATED REPORTS

Global Chrysalis Oil Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-26N13078
Fri Mar 21 00:00:00 UTC 2025

Add to Cart

Global Eucommia Ulmoides Extract Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-3L13782
Fri Mar 21 00:00:00 UTC 2025

Add to Cart

Global MRSA Drugs Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-26S13718
Fri Mar 21 00:00:00 UTC 2025

Add to Cart

Global Ferrous Citrate Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-16S12875
Fri Mar 21 00:00:00 UTC 2025

Add to Cart